PubMed=27642008; DOI=10.1186/s13041-016-0265-8; PMCID=PMC5027634
Sugai K., Fukuzawa R., Shofuda T., Fukusumi H., Kawabata S., Nishiyama Y., Higuchi Y., Kawai K., Isoda M., Kanematsu D., Hashimoto-Tamaoki T., Kohyama J., Iwanami A., Suemizu H., Ikeda E., Matsumoto M., Kanemura Y., Nakamura M., Okano H.
Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases.
Mol. Brain 9:85.1-85.15(2016)

PubMed=28233934; DOI=10.1002/jnr.24014
Kikuchi T., Morizane A., Doi D., Okita K., Nakagawa M., Yamakado H., Inoue H., Takahashi R., Takahashi J.
Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains.
J. Neurosci. Res. 95:1829-1837(2017)

PubMed=28858313; DOI=10.1038/nature23664
Kikuchi T., Morizane A., Doi D., Magotani H., Onoe H., Hayashi T., Mizuma H., Takara S., Takahashi R., Inoue H., Morita S., Yamamoto M., Okita K., Nakagawa M., Parmar M., Takahashi J.
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
Nature 548:592-596(2017)

PubMed=35176664; DOI=10.1016/j.scr.2022.102704
Kamiya D., Yamashita T., Akaboshi T., Yamaguchi Y., Toyooka Y., Ikeya M.
Generation of human GAPDH knock-in reporter iPSC lines for stable expression of tdTomato in pluripotent and differentiated culture conditions.
Stem Cell Res. 60:102704-102704(2022)